
Galderma releases data on temple hollowing treatment
Pharmaceutical company Galderma has released topline results from a randomised study evaluating its hyaluronic acid filler, Restylane Volyme, for moderate-to-severe temple hollowing. The study, involving 162 patients in China, found









